Aspen Aerogels, Inc. (NYSE:ASPN) Shares Sold by Castleark Management LLC

Castleark Management LLC cut its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 22.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 177,874 shares of the construction company's stock after selling 50,290 shares during the period. Castleark Management LLC owned approximately 0.22% of Aspen Aerogels worth $4,925,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Driehaus Capital Management LLC lifted its stake in shares of Aspen Aerogels by 130.4% in the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company's stock valued at $51,439,000 after purchasing an additional 1,220,724 shares during the last quarter. FMR LLC lifted its stake in shares of Aspen Aerogels by 23.6% in the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company's stock valued at $112,169,000 after purchasing an additional 773,647 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company's stock valued at $18,382,000 after purchasing an additional 654,350 shares during the last quarter. Millennium Management LLC bought a new stake in shares of Aspen Aerogels in the 2nd quarter valued at approximately $9,339,000. Finally, Renaissance Technologies LLC bought a new stake in shares of Aspen Aerogels during the 2nd quarter worth approximately $8,340,000. 97.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the company. HC Wainwright reissued a "buy" rating and set a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Wednesday, November 13th. TD Cowen raised their price target on Aspen Aerogels from $36.00 to $41.00 and gave the stock a "buy" rating in a research note on Tuesday, August 20th. Roth Mkm decreased their price target on Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a research note on Friday, November 8th. Finally, Barclays decreased their price target on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research note on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $28.70.

Aspen Aerogels Stock Down 0.9 %

Aspen Aerogels stock traded down $0.12 during midday trading on Friday, hitting $13.36. 1,742,438 shares of the company's stock were exchanged, compared to its average volume of 2,642,037. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a 12 month low of $10.75 and a 12 month high of $33.15. The firm has a 50-day moving average of $18.60 and a two-hundred day moving average of $23.45. The company has a market cap of $1.10 billion, a PE ratio of 1,336.00 and a beta of 2.11.

Insiders Place Their Bets

In other news, CEO Donald R. Young sold 63,355 shares of the firm's stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.30% of the stock is owned by company insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.